Qiao Li
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Conjugated deoxycholic acid-microbiota interaction mitigate liver cirrhosis via inducing anti-inflammation response of macrophages.
Journal: International immunopharmacology
Published: July 14, 2025
Autophagy of Kupffer cells modulates CD8+ T cell activation in primary biliary cholangitis.
Journal: Gut
Published: April 15, 2025
Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy.
Journal: Journal for immunotherapy of cancer
Published: January 04, 2024
Peripheral Th and NK cells are associated with response to lenvatinib plus PD-1 inhibitor in unresectable hepatocellular carcinoma.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 21, 2022
Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.
Journal: Hepatology international
Published: October 11, 2021
High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular Carcinoma.
Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research
Published: February 19, 2020
TanshinoneⅡA phenanthroimidazole derivative polarizes macrophage to improve metabolic homeostasis.
Journal: Biochemical and biophysical research communications
Published: April 25, 2019
Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma.
Journal: Frontiers in microbiology
Published: March 06, 2019
Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: April 13, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026